Navigation Links
Heartburn Meds May Often Be Taken for Too Long, at Too-High Doses

FRIDAY, Feb. 22 (HealthDay News) -- U.S. veterans with chronic heartburn are often prescribed higher-than-recommended doses of medicines to control the condition and many are kept on the drugs far too long, according to a new study.

Researchers looked at 1,600 veterans who were diagnosed with chronic heartburn -- also known as gastroesophageal reflux disease (GERD) -- and prescribed a type of drug called a "proton pump inhibitor," such as Prilosec (omeprazole).

GERD arises when the ring of muscle between the esophagus and stomach fails to close properly, allowing stomach acids to splash up into the esophagus. The main symptom is chronic heartburn.

These drugs -- which also include Prevacid (lansoprazole) and Nexium (esomeprazole) -- are among the most widely used drugs in the United States and provide relief for many patients with chronic heartburn. However, proper prescribing is required to avoid prolonged and unnecessary use, according to study first author Dr. Andrew Gawron, a fellow in the gastroenterology division and the Center for Healthcare Studies at Northwestern University Feinberg School of Medicine, in Chicago.

He and his colleagues found that most of the veterans in the study received more than a three-month initial supply of proton pump inhibitor medication and that nearly one-quarter of them were given high doses.

Only a few of the patients who were started on a high dose of this kind of medication had reductions in dosing more than two years after their initial prescription, according to the study published Feb. 16 in the Journal of General Internal Medicine.

The researchers noted that it is recommended that proton pump inhibitors be prescribed at the lowest effective dose for the first four to eight weeks. If symptoms persist after eight weeks, doctors should try to find other potential causes of symptoms and different types of treatment.

"We should always have a reevaluation after an initial prescription and ask, 'Does this patient need to be on this medication?'" Gawron said in a university news release.

However, he said this study shows that "once these veterans are prescribed a [proton pump inhibitor], they are rarely taken off of it. Two years after their initial prescription, most are still on the drug."

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about GERD.

-- Robert Preidt

SOURCE: Northwestern University, news release, Feb. 20, 2013

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Chronic Heartburn Could Spur Asthma in Some Patients
2. Remedies For Heartburn
3. How Heartburn No More Can Help People Treat Acid Reflux Permanently - Tony Nguyen
4. Tips for Holiday Heartburn Relief
5. Untreated Heartburn May Raise Risk for Esophageal Cancer, Study Says
6. Chronic Heartburn May Boost Risk for Esophageal Cancer
7. Patients Often Ill-Informed on Impact of Heart Device
8. Watch and Wait Approach Often Best for Older Patients With Kidney Cancer
9. Alcohol abusers depression often related to drinking
10. Shift to Hospice Care Often Comes Too Late, Study Finds
11. School Bullies Often Popular, Survey Finds
Post Your Comments:
Related Image:
Heartburn Meds May Often Be Taken for Too Long, at Too-High Doses
(Date:12/1/2015)... ... 2015 , ... Dr. Paul Vitenas, one of the top cosmetic surgeons ... magazine as the Best Single Physician Practice in the nation. Dr. Vitenas and his ... honored by the industry publication. , Dr. Vitenas said he was very honored ...
(Date:12/1/2015)... ... December 01, 2015 , ... Growth in medical payments per workers’ compensation claim ... of hospital and nonhospital care, according to a recent study by the Workers Compensation ... Edition , found medical payments per claim with more than seven days of lost ...
(Date:12/1/2015)... York, NY (PRWEB) , ... December 01, 2015 ... ... epidemic in the 1980s we have seen vast improvements in scientific research and ... made significant strides, providing increased hope and relief to those affected by HIV/AIDS. ...
(Date:12/1/2015)... ... December 01, 2015 , ... It’s official: Tattoo taboo is ... a number even greater among Millennials (a whopping one in three aged 18 to ... people who are dissatisfied with their ink. In fact, RealSelf , the world’s ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... amputations in the United States. Podiatrists are well aware that psychology-based patient non-compliance ... behaviors) are often catastrophic contributors to diseases of the diabetic foot. The ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: ... of chronic pain, announced today that the company will present ... held December 1-3 at the Luxe Sunset Boulevard Hotel in ... , CEO of Relmada Therapeutics, will present on Thursday, December ... . Please register at least 10 minutes ...
(Date:12/1/2015)... ANGELES , Dec. 1, 2015 CytRx ... development company specializing in oncology, today announced that it ... the company,s pivotal global Phase 3 clinical trial of ... (STS). Enrollment was originally estimated to be completed in Q1 ... being conducted under a Special Protocol Assessment from the ...
(Date:12/1/2015)... CHESTERBROOK, Pa. , Dec. 1, 2015 /PRNewswire/ ... leader, announced the launch of CareFront, a first-of-its-kind ... of patients diagnosed with cancer. Designed to be ... newly diagnosed cancer patients with resources for their ... costs. The program also offers tools to help ...
Breaking Medicine Technology: